Biopharma Business Development Leader
BIOGRAPHY
Speaker
Abstract
The structure of N-linked glycans can play a critical role in the pharmacology of therapeutic proteins, potentially affecting immunogenicity, pharmacokinetics and pharmacodynamics. This makes the characterization of N-glycans an essential part of the biotherapeutic development process. Released glycan mapping is the preferred method used to identify glycosylation sites and total glycan composition. We present Agilent’s comprehensive workflow for N-linked glycan utilizing automated N-linked Glycan sample preparation and high-resolution LC-MS data analysis.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...